MARIETTA, Ga., June 10 /PRNewswire-FirstCall/ -- MiMedx Group, Inc. (OTC Bulletin Board: MDXG), an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today that it will present at the Sidoti & Company Semiannual New York Micro-Cap Conference in New York. Parker H. “Pete” Petit, Chairman and CEO, William C. Taylor, President and COO, and Michael J. Senken, CFO of MiMedx, are scheduled to present on Friday, June 25, at 10:40 a.m. Eastern Time at the Grand Hyatt, 109 East 42nd Street at Grand Central Terminal, New York, New York. This presentation will be available on the Company’s website, www.mimedx.com beginning the morning of the conference.
About the Company
MiMedx Group, Inc. (“MiMedx Group”) is an integrated developer, manufacturer and marketer of patent protected biomaterial-based products. The company is successfully emerging from a development-focused start-up into a fully integrated operating company with an experienced team poised to capitalize on its science and technology to generate rapid sales growth and profitability. Our mantra is “Repair, don’t replace” because our biochemists, engineers, designers and physicians believe it is better to augment repair when possible rather than replace traumatized, but otherwise healthy tissues and structures. Our platform technologies, HydroFix and CollaFix, have a vast number of potential applications in treating traumatized tissue and structures and we are focused on commercializing multiple applications of both technologies. In parallel, we are seeking strategic relationships, in selective categories, to more rapidly commercialize our technologies. HydroFix and CollaFix are trademarks of MiMedx Group, Inc.
SOURCE MiMedx Group, Inc.
